Evidence map›Paper›PMID 33914187›Full record

ReviewInsights into imaging2021

Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art.

Alfredo Páez-Carpio, Fernando M Gómez, Gemma Isus Olivé, Pilar Paredes, Tarik Baetens, Enrique Carrero, Marcelo Sánchez, Ivan Vollmer

Open access · goldAbstract readReview
In one paragraph

Review in Insights into imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. An Interventional Radiologist's Guide to Lung Cancer.Seminars in interventional radiology · 2024
    Review
  19. [Recent Advances in Diagnosis and Treatment Strategies for Multiple Primary Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2023
    Article
  20. Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer:AJR. American journal of roentgenology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Alfredo Páez-CarpioDepartment of Radiology, CDI, Hospital Clínic, University of Barcelona, Barcelona, Spain. paez@clinic.cat.ORCID http://orcid.org/0000-0001-9791-5888
Fernando M GómezDepartment of Radiology, CDI, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Gemma Isus OlivéDepartment of Radiology, CDI, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Pilar ParedesDepartment of Nuclear Medicine, CDI, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Tarik BaetensDepartment of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Enrique CarreroDepartment of Anesthesiology, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Marcelo SánchezDepartment of Radiology, CDI, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Ivan VollmerDepartment of Radiology, CDI, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Universitat de Barcelona · ESThe Netherlands Cancer Institute · NLHospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications.

Indexed as

Metastatic lung diseaseNon-small cell lung carcinomaPercutaneous thermal ablation

Identifiers

PMID33914187
PMCPMC8085189
OpenAlexW3157154227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.